Evidence map›Paper›PMID 37009355›Full record

ReviewCureus2023

Evolving Coronary Stent Technologies - A Glimpse Into the Future.

Smeet Patel, Kalpen B Patel, Zeel Patel, Ashwati Konat, Ami Patel, Jinish S Doshi, Priyank Chokshi, Divya Patel, Kamal Sharma, MohmadSabir M Amdani and 3 more

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 2 countries.

Smeet PatelMedicine, New York University School of Global Public Health, New York City, USA.
Kalpen B PatelInternal Medicine, Pandit Deendayal Upadhyay Medical College, Rajkot, IND.
Zeel PatelMedicine, New York University School of Global Public Health, New York City, USA.
Ashwati KonatZoology, Biomedical Technology, and Human Genetics, Gujarat University, Ahmedabad, IND.
Ami PatelAnesthesiology, Overlook Medical Center, Atlantic Health System, Summit, USA.
Jinish S DoshiInternal Medicine, Ameer-ud-Din Medical College (AMC) Medical Education Trust (MET), Ahmedabad, IND.
Priyank ChokshiInternal Medicine, Pandit Deendayal Upadhyay Medical College, Rajkot, IND.
Divya PatelInternal Medicine, Byramjee Jeejabhoy Medical College, Ahmedabad, IND.
Kamal SharmaCardiology, Dr. Kamal Sharma Cardiology Clinic, Ahmedabad, IND.
MohmadSabir M AmdaniInternal Medicine, Sheth Lallubhai Gordhandas Municipal General Hospital, Ahmedabad, IND.
Darshini B ShahMedicine, Gujarat Cancer Society (GCS) Medical College, Hospital, and Research Center, Ahmedabad, IND.
Urva DholuInternal Medicine, Gujarat Cancer Society (GCS) Medical College, Hospital, and Research Center, Ahmedabad, IND.
Merik PatelPublic Health, New York University School of Global Public Health, New York City, USA.
City University of New York · USGujarat Cancer Society · INPandit Deendayal Petroleum University · INB.J. Medical College · INEducation Trust · USGujarat University · INIndus University · INOverlook Medical Center · USPublic Health Solutions · USSmt. N.H.L. Municipal Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most widely accepted forms of treatment for coronary artery disease (CAD) is the implementation of stents into the vessel. This area of research is constantly evolving, ranging from bare-metal stents through drug-eluting stents and, more recently, approaching bioresorbable stents and polymer-free stents. This article reviews the evolution of all these devices and emphasizes how they might be further evolved to provide an optimal coronary stent and overcome unsolved challenges in stent development. We thoroughly evaluated a number of published studies in order to advance coronary stent technologies. Additionally, we looked for various literature that highlighted the inadequacies of the coronary stents that are currently available and how they might be modified to create the optimum coronary stent. Coronary stents have significantly improved clinical outcomes in interventional cardiology, but there are still a number of drawbacks, including an persisted risk of thrombosis due to endothelial injury and in-stent restenosis. Gene eluting stents (GES) and customized coronary stents with self-reporting stent sensors are appealing alternatives to existing stent approaches. Considering the adequacy of these gene eluting stents (GES), customized coronary stents produced by novel 4D printing technologies and integrated self-reporting stent sensors should be assumed for anticipating future advancements to optimal coronary stent devices; however, more interventional evidence is required to determine the future prospects of these stent innovations.

Indexed as

coronary artery diseasesgene-eluting stentsin-stent restenosisstent optimizationstentsstent sensors

Identifiers

PMID37009355
PMCPMC10065169
OpenAlexW4322732330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.